Control of prostate cancer by transrectal HIFU in 227 patients. - Wikidata - awgldk - TriplyDB

Control of prostate cancer by transrectal HIFU in 227 patients.

Control of prostate cancer by transrectal HIFU in 227 patients.

http://www.wikidata.org/entity/Q50249664

about

High-Intensity Focused Ultrasound (HIFU) in Localized Prostate Cancer Treatment High-intensity focused ultrasound (HIFU) for definitive treatment of prostate cancer Spatial and Temporal Control of Hyperthermia Using Real Time Ultrasonic Thermal Strain Imaging with Motion Compensation, Phantom Study.Bubbles with shock waves and ultrasound: a review.Boiling histotripsy lesion characterization on a clinical magnetic resonance imaging-guided high intensity focused ultrasound system Rapid full-wave phase aberration correction method for transcranial high-intensity focused ultrasound therapies.Hollow iron-silica nanoshells for enhanced high intensity focused ultrasound.Cavitation-enhanced MR-guided focused ultrasound ablation of rabbit tumors in vivo using phase shift nanoemulsions.Magnetic resonance-guided focused ultrasound surgery: Part 2: A review of current and future applications.First clinical experience of intra-operative high intensity focused ultrasound in patients with colorectal liver metastases: a phase I-IIa study.MR imaging-guided interventions in the genitourinary tract: an evolving concept.MRI-guided focused ultrasound surgery.Accumulation of phase-shift nanoemulsions to enhance MR-guided ultrasound-mediated tumor ablation in vivo Image-guided tumor ablation: emerging technologies and future directions.Optimization of encoding gradients for MR-ARFI High-intensity-focused ultrasound in the treatment of primary prostate cancer: the first UK series.Adaptive transthoracic refocusing of dual-mode ultrasound arrays Transrectal high-intensity focused ultrasound for the treatment of prostate cancer: past, present, and future.In vivo monitoring of focused ultrasound surgery using local harmonic motion Traditional Indian medicine and homeopathy for HIV/AIDS: a review of the literature.Acoustic characterization of high intensity focused ultrasound fields: a combined measurement and modeling approach.High-intensity focused ultrasound therapy: an overview for radiologists Treatment of esophageal tumors using high intensity intraluminal ultrasound: first clinical results Simulation study on the heating of the surrounding anatomy during transurethral ultrasound prostate therapy: a 3D theoretical analysis of patient safety.Focal therapy in the management of localized prostate cancer.Single high intensity focused ultrasound session as a whole gland primary treatment for clinically localized prostate cancer: 10-year outcomes High intensity focused ultrasound (HIFU) for prostate cancer: current clinical status, outcomes and future perspectives.HIFU ablation is not a proven standard treatment for localized prostate cancer Continence rate and oncological feasibility after total transurethral resection of the prostate as an alternative therapy for the treatment of prostate cancer: a pilot study.Holmium laser enucleation of the prostate followed by high-intensity focused ultrasound treatment for patients with huge prostate adenoma and localized prostate cancer: 5-Year follow-up.High-intensity focused ultrasound for prostate cancer: long-term followup and complications rate.Salvage radiotherapy after high-intensity focused ultrasound treatment for localized prostate cancer: feasibility, tolerance and efficacy.High-intensity focused ultrasound (HIFU) for prostate cancer.High-intensity focused ultrasound in prostate cancer; a systematic literature review of the French Association of Urology.Minimally invasive surgical modalities in the management of localized prostate cancer.Comparisons of oncological and functional outcomes among radical retropubic prostatectomy, high dose rate brachytherapy, cryoablation and high-intensity focused ultrasound for localized prostate cancer.Techniques of interventional tumor therapy.Efficacy of high-intensity focused ultrasound-assisted hepatic resection (HIFU-AR) on blood loss reduction in patients with liver metastases requiring hepatectomy: study protocol for a randomized controlled trial.High-intensity focused ultrasound: where are we and where to from here?Transrectal high-intensity focused ultrasound (HIFU) treatment of localized prostate cancer: review of technical incidents and morbidity after 5 years of use.

P2860

Q26823776-58FE669E-33B5-421F-B637-7DDC04EB711C Q26996937-E2C147BB-C1E9-47E1-8F67-E614CD54F271 Q27300981-181F8974-E9B2-48C8-BDE6-05D3FABAA49A Q27347252-1E762B1D-493E-4078-B98D-6CFAE57ADB2C Q30359377-2D91495E-E4E3-4317-8417-323D13AC0146 Q30367912-232AEDAF-CBAF-49A4-A26B-41EA00DDE834 Q30405849-82B9C989-CADE-49DC-81AC-69814AF26F1A Q30407447-7660467D-0216-42D1-8E57-83488201A09C Q30411823-501FA71D-0804-42DC-AF26-9ACECB4247F9 Q30417323-C832E89C-2520-4D98-9FF3-5643EABD994B Q30435975-1D5604A2-2841-4B4F-92EB-4C3F5337860D Q30439347-793F39A3-C3BA-498E-9AD6-D54428D70275 Q30443425-74079789-63A3-4FD5-9687-C986F25B2AB8 Q30468191-FD95C8E8-1A41-4E9C-BC3A-FD6C562B70F2 Q30476102-99FDED1E-A555-47DD-BEC7-C1A0DCFC1D5C Q30480603-AA52773B-9F20-434C-B057-6FA2BEB6D498 Q30480905-2B467184-739C-413B-AC8B-A90F91F91AFA Q30481118-2AA8C086-FE7C-487F-95DA-758A9B2FEB7E Q30484453-6F63778F-9B0D-4C52-9070-00D77438A830 Q30485862-4D930860-CD6F-4F11-8084-3AC171F7DBED Q30486302-7E4C72AA-F3E3-41E9-861C-25F2CAB5A5BB Q30491226-7E0C605C-2633-4769-91BC-51153674EA74 Q30494185-A192E342-F2BF-45C2-8AE8-26838F34D9A7 Q33633253-B202FA59-E058-4C25-98C4-23E9D850CC7F Q33790382-8599D43C-F51E-488A-85DD-7FAD41E441F0 Q33873770-775BF610-6B12-4098-853A-36F1239F68B0 Q34024161-D2D0E490-9878-49C2-9C9E-DD1F78AE7A31 Q35605743-7EBF9728-EDC5-4422-9667-32FF1A176AD0 Q35667314-067AE496-3847-4858-B5FF-572D539AED0F Q36064539-028794ED-1623-4397-B193-BC80985B6105 Q36184597-E56EE92B-468C-45EC-84F2-AA643BE83384 Q36338964-58D53605-5905-4076-97FF-A90AC318BD53 Q36872271-5F2D7718-D28F-4604-B035-B9F653C64953 Q37103993-EE5EAC32-7300-44F0-ACB8-7D897E4A04FA Q37183470-E46C36B2-BAF8-4C85-B8A2-DA2E3CA0D760 Q37393032-CA675ECE-F86B-4AD1-AAC3-54FE745908DC Q37496689-ED5D16FB-3FF4-4AC3-9E9B-30BB2126312A Q37627898-7CB7AFEC-71B6-4E74-81B0-464AA9592507 Q37656210-C24F51B3-C460-4842-8403-7FB18586B9F9 Q37667867-217F2F3D-74CD-47F4-9018-2B08170722A9

P2860

Control of prostate cancer by transrectal HIFU in 227 patients.

http://www.wikidata.org/entity/Q50249664

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

2006年學術文章

@zh-hant

name

Control of prostate cancer by transrectal HIFU in 227 patients.

@en

Control of prostate cancer by transrectal HIFU in 227 patients.

@nl

type

label

Control of prostate cancer by transrectal HIFU in 227 patients.

@en

Control of prostate cancer by transrectal HIFU in 227 patients.

@nl

prefLabel

Control of prostate cancer by transrectal HIFU in 227 patients.

@en

Control of prostate cancer by transrectal HIFU in 227 patients.

@nl

P1433

Q50249664-B1BA4102-A7E1-4B92-8088-4573067CE6BE

P1476

Q50249664-86CC889F-2189-463F-9A37-6E26BCFF99DF

P2093

Q50249664-0819CAC4-E0E8-41FF-A229-64622BADB5BB

Q50249664-5593483B-689B-4659-80D8-D6D1AFC01106

Q50249664-748CF1F2-5C1B-41E3-B04C-94742C6E1EA6

Q50249664-C1B6403D-6C28-439F-9351-805E95839E8C

Q50249664-DFC62509-0D7E-46C2-95CF-C015B917CAAF

Q50249664-EB7477F7-1BAD-4DB8-B5DF-902C7824BBEB

Q50249664-EC65A603-6A78-4962-BFCC-E7062F9AB806

P304

Q50249664-CEED4F6F-B5ED-4568-90F7-F43896A15365

P31

Q50249664-1A0EAEF3-4895-4CA5-9EDB-8B6CB4BF4E42

P356

Q50249664-08B2DA33-5618-4A80-85F8-91DBE2A2B4A6

P407

Q50249664-5B911FCA-2F00-4169-BD2D-51FFA3757334

P433

Q50249664-0FB26E1D-7665-418D-A2D5-8B910CAB3924

P478

Q50249664-C1E79BE4-2FB2-4300-B5C6-FEEB6E042FD9

P50

Q50249664-D7A02C67-410A-4292-B67A-825493905812

P577

Q50249664-F546A96C-8D31-42D5-AC9E-CFCE82BF0F2D

P698

Q50249664-13B8DF63-6510-4E0A-B40E-504DF97116C6

P356

J.EURURO.2006.04.012

P1433

European Urology

P1476

Control of prostate cancer by transrectal HIFU in 227 patients.

@en

P2093

Albert Gelet

http://www.w3.org/2001/XMLSchema#string

Jean Michel Dubernard

http://www.w3.org/2001/XMLSchema#string

Jean-Yves Chapelon

http://www.w3.org/2001/XMLSchema#string

Laura Curiel

http://www.w3.org/2001/XMLSchema#string

Laura Poissonnier

http://www.w3.org/2001/XMLSchema#string

Raymonde Bouvier

http://www.w3.org/2001/XMLSchema#string

Xavier Martin

http://www.w3.org/2001/XMLSchema#string

P304

381-387

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.EURURO.2006.04.012

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

51

http://www.w3.org/2001/XMLSchema#string

P50

Olivier Rouviere

P577

2006-05-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16857310

http://www.w3.org/2001/XMLSchema#string